Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer
Tóm tắt
This study aimed to develop and evaluate an automatic model using artificial intelligence (AI) for quantifying vascular involvement and classifying tumor resectability stage in patients with pancreatic ductal adenocarcinoma (PDAC), primarily to support radiologists in referral centers. Resectability of PDAC is determined by the degree of vascular involvement on computed tomography scans (CTs), which is associated with considerable inter-observer variability. We developed a semisupervised machine learning segmentation model to segment the PDAC and surrounding vasculature using 613 CTs of 467 patients with pancreatic tumors and 50 control patients. After segmenting the relevant structures, our model quantifies vascular involvement by measuring the degree of the vessel wall that is in contact with the tumor using AI-segmented CTs. Based on these measurements, the model classifies the resectability stage using the Dutch Pancreatic Cancer Group criteria as either resectable, borderline resectable, or locally advanced (LA). We evaluated the performance of the model using a test set containing 60 CTs from 60 patients, consisting of 20 resectable, 20 borderline resectable, and 20 locally advanced cases, by comparing the automated analysis obtained from the model to expert visual vascular involvement assessments. The model concurred with the radiologists on 227/300 (76%) vessels for determining vascular involvement. The model’s resectability classification agreed with the radiologists on 17/20 (85%) resectable, 16/20 (80%) for borderline resectable, and 15/20 (75%) for locally advanced cases. This study demonstrates that an AI model may allow automatic quantification of vascular involvement and classification of resectability for PDAC. This AI model enables automated vascular involvement quantification and resectability classification for pancreatic cancer, aiding radiologists in treatment decisions, and potentially improving patient outcomes. • High inter-observer variability exists in determining vascular involvement and resectability for PDAC. • Artificial intelligence accurately quantifies vascular involvement and classifies resectability for PDAC. • Artificial intelligence can aid radiologists by automating vascular involvement and resectability assessments.
Tài liệu tham khảo
Chhoda A, Lu L, Clerkin BM et al (2019) Current approaches to pancreatic cancer screening. Am J Pathol 189:22–35. https://doi.org/10.1016/j.ajpath.2018.09.013
Giannone F, Capretti G, Hilal MA et al (2021) Resectability of pancreatic cancer is in the eye of the observer: a multicenter, blinded, prospective assessment of interobserver agreement on NCCN resectability status criteria. Ann Surg Open 2:e087. https://doi.org/10.1097/AS9.0000000000000087
Mostafa ME, Erbarut-Seven I, Pehlivanoglu B, Adsay V (2018) Pathologic classification of “pancreatic cancers”: current concepts and challenges. Chin Clin Oncol 6:59–59. https://doi.org/10.21037/cco.2017.12.01
Rigiroli F, Hoye J, Lerebours R et al (2021) CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: a pilot study. Radiology 301:610–622. https://doi.org/10.1148/radiol.2021210699
Tirkes T, Chen X, Petrucciani N, et al (2022) Radiomics-assisted presurgical prediction for surgical portal vein-superior mesenteric vein invasion in pancreatic ductal adenocarcinoma. Front Oncol 10:523543. https://doi.org/10.3389/fonc.2020.523543
Bian Y, Jiang H, Ma C et al (2020) Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer. Abdom Radiol (NY) 45:759–773. https://doi.org/10.1007/s00261-019-02401-9
Lao Y, David J, Fan Z et al (2020) Quantifying vascular invasion in pancreatic cancer—a contrast CT based method for surgical resectability evaluation. Phys Med Biol 65:105012. https://doi.org/10.1088/1361-6560/ab8106
Janssen QP, van Dam JL, Bonsing BA et al (2021) Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer 21:300. https://doi.org/10.1186/s12885-021-08031-z
Van Tienhoven G, Versteijne E, Suker M, et al (2018) Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): a randomized, controlled, multicenter phase III trial. J Clin Oncol 36:LBA4002–LBA4002. https://doi.org/10.1200/JCO.2018.36.18_suppl.LBA4002
Walma MS, Rombouts SJ, Brada LJH et al (2021) Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial. Trials 22:313. https://doi.org/10.1186/s13063-021-05248-y
Simpson AL, Antonelli M, Bakas S, et al (2019) A large annotated medical image dataset for the development and evaluation of segmentation algorithms. arXiv preprint arXiv:190209063. https://doi.org/10.48550/arXiv.1902.09063
Fedorov A, Beichel R, Kalpathy-Cramer J et al (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30:1323–1341. https://doi.org/10.1016/j.mri.2012.05.001
Alves N, Schuurmans M, Litjens G et al (2022) Fully automatic deep learning framework for pancreatic ductal adenocarcinoma detection on computed tomography. Cancers 14:376. https://doi.org/10.3390/cancers14020376
Zhang L, Shi Y, Yao J, et al (2020) Robust pancreatic ductal adenocarcinoma segmentation with multi-institutional multi-phase partially-annotated CT scans. In: International Conference on Medical Image Computing and Computer-Assisted Intervention. Springer, pp 491–500. https://doi.org/10.48550/arXiv.2008.10652
Ronneberger O, Fischer P, Brox T (2015) U-net: Convolutional networks for biomedical image segmentation. In: International Conference on Medical image computing and computer-assisted intervention. Springer, pp 234–241. https://doi.org/10.48550/arXiv.1505.04597
Isensee F, Jaeger PF, Kohl SA et al (2021) nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods 18:203–211. https://doi.org/10.1038/s41592-020-01008-z
Dutch Pancreatic Cancer Group (DPCG) Criteria Resectabiliteit. Available via https://dpcg.nl/richtlijnen/
Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028–1061. https://doi.org/10.6004/jnccn.2017.0131